Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Molecular targeted therapy and genomic evolution of breast cancer].

Nihon rinsho. Japanese journal of clinical medicine - 1 Aug 2015

Sato Fumiaki, Toi Masakazu

Abstract excerpt

Owing to development of next generation sequencer (NGS), deep biological insights of breast cancer have been provided. Information of genomic mutations and rearrangements in patients' tumors is required to understand the mechanism in resistance of molecular targeted medicine. To date, NGS analyses illustrated not only base substitution patterns and lists of driver mutations and key rearrangements, but also a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Monoclonal, Humanized
Share to Bevacizumab
Share to Everolimus

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to RANK Ligand

Share to Receptor, ErbB-2

Share to Sirolimus

Share to TOR Serine-Threonine Kinases

Share to Trastuzumab

Source

Identifiers

PMID: 26281691

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Molecular targeted therapy and genomic evolution of breast cancer].PMID 26281691Read ↗

Genomic tumor evolution of breast cancer.Semantic proximity Read ↗

[The genetic basis and clinical application of heterogeneity of breast cancer].Semantic proximity Read ↗

Catalog of genetic progression of human cancers: breast cancer.Semantic proximity Read ↗

[Advancement of next generation sequencing in breast cancer].Semantic proximity Read ↗

Recent advances of therapeutic targets based on the molecular signature in breast cancer: genetic mutations and implications for current treatment paradigmsSemantic proximity Read ↗

Breast Cancer: A Molecularly Heterogenous Disease Needing Subtype-Specific TreatmentsSemantic proximity Read ↗

Precision medicine in breast cancer: genes, genomes, and the future of genomically driven treatments.Semantic proximity Read ↗

Insight into the heterogeneity of breast cancer through next-generation sequencing.Semantic proximity Read ↗

Current advances in the diagnosis and personalized treatment of breast cancer: lessons from tumor biology.Semantic proximity Read ↗

[Current situation and prospect of breast cancer liquid biopsy].Semantic proximity Read ↗

Current Progresses of Single Cell DNA Sequencing in Breast Cancer ResearchSemantic proximity Read ↗

Genetic Signature of Breast Cancer Defines Therapeutic Interventions and Indicates Early Drug Resistance.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.